• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Carbon reduction plan requirements for procurement
In April 2023, the NHS will require all suppliers of new contracts for goods, services and/or works with an anticipated contract value above £5 million per year (excluding VAT) to publish a carbon reduction plan (CRP) for their emissions from the sources included in scope 1 and 2 of the Greenhouse Gas Protocol, and a defined subset of scope 3 emissions, aligning with the government’s procurement policy note (PPN) 06/21: Taking account of CRPs in the procurement of major government contracts.
Source: NHS Networks - March 1, 2023 Category: UK Health Source Type: news

Carbon reduction plan requirements for the procurement of NHS goods, services and works
NHS England - In April 2023, the NHS will require all suppliers of new contracts for goods, services, and/or works with an anticipated contract value above £5 million per year (excluding VAT) to publish a carbon reduction plan (CRP) for their emissions from the sources included in scope 1 and 2 of the Greenhouse Gas (GHG) Protocol, and a defined subset of scope 3 emissions, aligning with the government’s procurement policy note (PPN) 06/21:Taking account of CRPs in the procurement of major government contracts. This document outlines how this requirement will be applied in an NHS context and is intended to be used...
Source: Health Management Specialist Library - February 27, 2023 Category: UK Health Authors: The King ' s Fund Library Tags: NHS finance Source Type: blogs

SPR Therapeutics touts first CRPS treatment with Sprint PNS
SPR Therapeutics said today that it launched its FDA-cleared Sprint Endura single-lead peripheral nerve stimulation system intended for treating complex regional pain syndrome. Complex regional pain syndrome is a chronic pain condition affecting the limbs that can be caused by trauma, injury or surgery. The Cleveland-based company said that the device was used in its first commercial procedure by Dr. Marc Huntoon of VCU Medical Center. “I have been treating complex regional pain syndrome, a condition known as CRPS, for nearly three decades. In my experience, patients suffering chronic pain benefit from early interve...
Source: Mass Device - November 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blog SPR Therapeutics Source Type: news